Sleeve gastrectomy with intestinal bypass for severe obesity
Part of Hormones & metabolism clinical trials.
This study tests a new surgery that combines a smaller stomach (sleeve gastrectomy) with a rerouting of part of the intestine, which may lead to more weight loss and better control of conditions like type 2 diabetes. The purpose is to see if this procedure is safe and effective for people with severe obesity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your weight is high enough that your body mass index (BMI) is at least 35, or you have a BMI of 30-34.9 with a weight-related health issue like type 2 diabetes.
- You have not had any prior weight-loss surgery (unless you had a previous sleeve gastrectomy and are eligible for a revisional procedure).
- You are willing to commit to follow-up appointments and tests for at least 12 months after the surgery.
- You are not pregnant or planning to become pregnant during the next year.
- You do not have serious health conditions that would make surgery unsafe (e.g., severe liver or kidney disease, active cancer, or uncontrolled mental illness).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a type of weight-loss surgery (called metabolic surgery) to see if it helps people with type 2 diabetes achieve better blood sugar control. It's for people who have struggled to manage their diabetes with standard treatments and have a BMI between 30 and 35.
This study looks at complications after a type of weight-loss surgery called sleeve gastrectomy (removing part of the stomach). If you are considering this surgery and meet the weight/health guidelines, you may be able to join to help doctors learn more about risks and recovery.
This trial studies a specific type of metabolic (weight-related) surgery for people whose sleeve gastrectomy did not lead to enough weight loss or has caused significant weight regain. It may help improve long-term weight and related health problems.
This study tests a weight-loss procedure called endoscopic sleeve gastroplasty (a stomach-reducing procedure done through a scope) in people with both obesity and inflammatory bowel disease (IBD). It aims to see if the procedure is safe and helpful for this group.
This trial tests a tube-like device placed in the upper gut to help people with obesity and related health problems lose weight. It may be an option if you haven't lost a lot of weight recently or taken certain medications.
This study tests a non-surgical procedure called an endoscopic sleeve (Endosleeve) to help with weight loss in people with obesity. It's done through a scope placed in your mouth and stomach—no cuts needed—and aims to shrink your stomach to help you feel full sooner and eat less.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.